APA (7th ed.) Citation

B, C., P, H., G, L., Y, L., PJC, L., BH, P., . . . DK, G. (2023). A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta. Frontiers in immunology, 14, 1135815. https://doi.org/10.3389/fimmu.2023.1135815

Chicago Style (17th ed.) Citation

B, Carter, et al. "A Pan-variant MRNA-LNP T Cell Vaccine Protects HLA Transgenic Mice from Mortality After Infection with SARS-CoV-2 Beta." Frontiers in Immunology 14 (2023): 1135815. https://doi.org/10.3389/fimmu.2023.1135815.

MLA (9th ed.) Citation

B, Carter, et al. "A Pan-variant MRNA-LNP T Cell Vaccine Protects HLA Transgenic Mice from Mortality After Infection with SARS-CoV-2 Beta." Frontiers in Immunology, vol. 14, 2023, p. 1135815, https://doi.org/10.3389/fimmu.2023.1135815.